Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
69.54
-0.66 (-0.94%)
At close: Nov 20, 2024, 4:00 PM
69.46
-0.08 (-0.12%)
Pre-market: Nov 21, 2024, 7:13 AM EST
Edwards Lifesciences Market Cap
Edwards Lifesciences has a market cap or net worth of $41.01 billion as of November 21, 2024. Its market cap has increased by 0.87% in one year.
Market Cap
41.01B
Enterprise Value
37.33B
1-Year Change
0.87%
Ranking
Category
Stock Price
$69.54
Market Cap Chart
Since March 27, 2000, Edwards Lifesciences's market cap has increased from $958.50M to $41.01B, an increase of 4,179.05%. That is a compound annual growth rate of 16.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 41.40B | -10.40% |
Dec 29, 2023 | 46.21B | 0.17% |
Dec 30, 2022 | 46.13B | -42.97% |
Dec 31, 2021 | 80.88B | 42.25% |
Dec 31, 2020 | 56.86B | 16.86% |
Dec 31, 2019 | 48.66B | 51.96% |
Dec 31, 2018 | 32.02B | 34.25% |
Dec 29, 2017 | 23.85B | 19.05% |
Dec 30, 2016 | 20.03B | 17.59% |
Dec 31, 2015 | 17.04B | 25.03% |
Dec 31, 2014 | 13.63B | 89.40% |
Dec 31, 2013 | 7.19B | -30.86% |
Dec 31, 2012 | 10.41B | 29.03% |
Dec 30, 2011 | 8.06B | -12.62% |
Dec 31, 2010 | 9.23B | 87.85% |
Dec 31, 2009 | 4.91B | 60.64% |
Dec 31, 2008 | 3.06B | 17.27% |
Dec 31, 2007 | 2.61B | -4.23% |
Dec 29, 2006 | 2.72B | 10.05% |
Dec 30, 2005 | 2.47B | 0.91% |
Dec 31, 2004 | 2.45B | 37.56% |
Dec 31, 2003 | 1.78B | 16.52% |
Dec 31, 2002 | 1.53B | -6.49% |
Dec 31, 2001 | 1.64B | 57.15% |
Dec 29, 2000 | 1.04B | 8.63% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Becton, Dickinson and Company | 64.77B |
Cencora | 47.60B |
Takeda Pharmaceutical | 42.85B |
Alcon | 42.70B |
Haleon | 41.86B |
GE HealthCare Technologies | 37.79B |
Agilent Technologies | 36.47B |
ResMed | 35.13B |